Review

Emerging Treatments for Psoriasis: What Do Interleukin-17 Antagonists Promise?
  • Burhan Engin
  • Muazzez Çiğdem Oba
  • Zekayi Kutlubay
  • Server Serdaroğlu
J Turk Acad Dermatol 2018; 12: 0-0 DOI: 10.6003/jtad.18123r2
TNF-α Antagonists in the Treatment of Nail Psoriasis
  • Zekayi Kutlubay
  • Burhan Engin
  • Abdullah Songür
  • Yalçın Tüzün
J Turk Acad Dermatol 2012; 6: 0-0 DOI: 10.6003/jtad.1264r1

Case Report

Multiple Lentigines in Resolving Psoriatic Plaques After Treatment with Secukinumab in Two Cases
  • Tuğba Kevser Uzunçakmak
  • Ayşe Serap Karadağ
  • Bengü Çobanoğlu Şimşek
J Turk Acad Dermatol 2023; 17: 80-82 DOI: 10.4274/jtad.galenos.2023.35229

Original Article

Demographic and Clinical Characteristics of Geriatric Patients with Psoriasis: A Single-center, Cross-sectional, Retrospective Study in Turkish Population
  • Tuğba Kevser Uzunçakmak
  • Selim Gümüş
  • Ayşenur Özdil Eser
  • Burhan Engin
J Turk Acad Dermatol 2023; 17: 92-96 DOI: 10.4274/jtad.galenos.2023.63325

About Journal

Forms

Useful Links